Comment
. 2006 Jan 5;354(1):94-6; author reply 94-6.
Drotrecogin alfa (activated) in severe sepsis
- PMID: 16395834
Item in Clipboard
Comment
Drotrecogin alfa (activated) in severe sepsis
N Engl J Med.
.
No abstract available
Comment on
-
Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death.N Engl J Med. 2005 Sep 29;353(13):1332-41. doi: 10.1056/NEJMoa050935. N Engl J Med. 2005. PMID: 16192478 Clinical Trial.
Similar articles
-
Drotrecogin alfa (activated) in severe sepsis.N Engl J Med. 2006 Jan 5;354(1):94-6; author reply 94-6. doi: 10.1056/NEJMc052759. N Engl J Med. 2006. PMID: 16394311 No abstract available.
-
Drotrecogin alfa (activated) in severe sepsis.N Engl J Med. 2006 Jan 5;354(1):94-6; author reply 94-6. N Engl J Med. 2006. PMID: 16395833 No abstract available.
-
Drotrecogin alfa (activated) in patients with severe sepsis and a high risk of death.Crit Care. 2006;10(6):427. doi: 10.1186/cc5117. Crit Care. 2006. PMID: 17214908 Free PMC article. No abstract available.
-
Efficacy and safety of drotrecogin alfa (activated) for the therapy of surgical patients with severe sepsis.Surg Infect (Larchmt). 2006;7 Suppl 2:S77-80. doi: 10.1089/sur.2006.7.s2-77. Surg Infect (Larchmt). 2006. PMID: 16895513 Review.
-
Pharmacology, clinical efficacy, and safety of drotrecogin alfa (activated).Pharmacotherapy. 2002 Dec;22(12 Pt 2):182S-195S. doi: 10.1592/phco.22.18.182s.33704. Pharmacotherapy. 2002. PMID: 12492225 Review.
Cited by
-
Medical guidelines and performance measures: the need to keep them free of industry influence.Mens Sana Monogr. 2008 Jan;6(1):22-8. doi: 10.4103/0973-1229.33005. Mens Sana Monogr. 2008. PMID: 22013347 Free PMC article. No abstract available.
-
Treatable traits and therapeutic targets: Goals for systems biology in infectious disease.Curr Opin Syst Biol. 2017 Apr;2:140-146. doi: 10.1016/j.coisb.2017.04.003. Epub 2017 Apr 27. Curr Opin Syst Biol. 2017. PMID: 32363252 Free PMC article. Review.
-
How many patients with severe sepsis are needed to confirm the efficacy of drotrecogin alfa activated? A Bayesian design.Intensive Care Med. 2008 Oct;34(10):1804-11. doi: 10.1007/s00134-008-1159-8. Epub 2008 May 27. Intensive Care Med. 2008. PMID: 18504550
-
Drotrecogin alfa (activated) should not be used in patients with severe sepsis and low risk for death.Crit Care. 2006;10(6):316. doi: 10.1186/cc5071. Crit Care. 2006. PMID: 17094794 Free PMC article. No abstract available.
-
Growing insights into the potential benefits and risks of activated protein C administration in sepsis: a review of preclinical and clinical studies.Biologics. 2009;3:391-406. doi: 10.2147/btt.2009.3547. Epub 2009 Sep 15. Biologics. 2009. PMID: 19774207 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical